The Telangana government has announced new investments at BioAsia 2025. Eleven companies will invest Rs 5,445 crore in Green Pharma City, creating 9,800 jobs. Major global companies like MSD, Agilisium, ALS, and Meishi Pharma are also investing in Telangana. Chief Minister Anumula Revanth Reddy aims to make Hyderabad a top biosciences hub.
A new life sciences policy will boost research, innovation, and manufacturing. Telangana already produces 20% of the world’s generic medicines and 40% of vaccines. The event also honored Dr. Patrick Tan for cancer research and explored collaborations with Queensland, Australia.
What is Green Pharma City?
Green Pharma City is a planned industrial park in Telangana, India, dedicated to pharmaceutical and life sciences companies. It aims to be a sustainable, eco-friendly hub for pharmaceutical research, manufacturing, and innovation. The Telangana government is developing it to attract investments, create jobs, and strengthen the state’s position as a global leader in the life sciences sector.
The project focuses on green energy, waste management, and world-class infrastructure to support the growing pharma industry. With major companies investing, Green Pharma City is set to become a key player in India’s pharmaceutical ecosystem.
Why is This Funding Significant?
This funding is highly significant as it strengthens Telangana’s position as a global leader in the life sciences sector. The Rs 5,445 crore investment will not only boost pharmaceutical research and manufacturing but also create 9,800 new jobs, providing employment opportunities and supporting economic growth. The entry of global companies like MSD, Agilisium, ALS, and Meishi Pharma highlights international confidence in Telangana’s business environment.
Additionally, the investment will drive innovation in advanced fields such as genomics, biologics, and precision medicine. Telangana already plays a crucial role in the pharmaceutical industry, contributing 20% to global generic drug production and 40% of vaccines.
With the government’s new life sciences policy and the development of pharma villages, this funding will further enhance infrastructure, promote high-end research, and establish Hyderabad as a leading global pharma hub.
How Will the Funds Be Used?
The funds will be used to develop Green Pharma City, expand life sciences research and manufacturing, and create new job opportunities in Telangana. A significant portion will go into building state-of-the-art infrastructure, including research labs, manufacturing units, and eco-friendly facilities. Companies like MSD, Agilisium, ALS, and Meishi Pharma will use the investment to set up new facilities, R&D centers, and innovation hubs.
The government will also use the funds to support advanced technologies like genomics, biologics, and precision medicine. Additionally, investments will help in the development of pharma villages, fostering long-term industry growth and making Hyderabad a global life sciences hub.
Founders’ Perspective
The vision behind Green Pharma City is driven by Telangana’s Chief Minister A. Revanth Reddy, who aims to position Hyderabad as a global life sciences hub while ensuring sustainability and innovation., industry leaders investing in Green Pharma City have expressed strong confidence in the project.
These perspectives underline a shared goal—transforming Green Pharma City into a world leader in life sciences while ensuring environmental sustainability and economic growth.
Key Takeaways
- Major Investment in Green Pharma City – Telangana secured Rs 5,445 crore in additional investments, bringing the total to Rs 11,100 crore, reinforcing its status as a life sciences hub.
- Job Creation & Economic Growth – The new investments will generate 9,800 direct jobs, with the potential to create nearly 22,300 jobs in total, boosting the local economy.
- Global Companies Enter Telangana – Leading multinational firms like MSD, Agilisium, ALS, and Meishi Pharma are setting up operations in Hyderabad, highlighting international confidence.
- New Life Sciences Policy – Telangana is launching a first-of-its-kind policy to expand into cell and gene therapy, biologics, precision medicine, and digital innovation.
- Sustainability & Innovation Focus – Green Pharma City aims to be India’s first net-zero carbon pharma hub, promoting eco-friendly industrial development.
Join Aman Raj & Gaurav in an exclusive discussion on Evahan’s rapid growth. Watch now! 👇
Conclusion
The Telangana government’s investment push in Green Pharma City marks a major step toward making the state a global life sciences powerhouse. With new policies, cutting-edge R&D, and strategic global partnerships, Hyderabad is set to lead in biotech, pharmaceuticals, and precision medicine. The focus on sustainability will ensure long-term industrial growth while maintaining environmental balance.
Future plans include expanding pharma villages, boosting infrastructure, and creating lakhs of jobs. As Telangana strengthens its position in global drug and vaccine production, these efforts will drive economic growth, innovation, and international collaboration, making Hyderabad a true hub of the future.
Invest in Innovation, Invest in Green Pharma City! Be part of India’s next big pharmaceutical success story.
